Guardian Health Management - Fresche Bioscience
Guardian Health Management is the India-headquartered exclusive regional distributor for Australia-based Fresche Bio-Sciences' Si QAC surface-bonded antimicrobial technology, serving healthcare, hospitality, textile, and institutional customers across South Asia with hospital-grade disinfectants, treatment services, and OEM licensing.
- Company typePrivate
- Founded-
- HeadquartersBengaluru (Bangalore), India
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Guardian Health Management - Fresche Bioscience does
Guardian Health Management Pvt Ltd is a Bengaluru-headquartered private Indian company operating as the exclusive regional representative for Australia-based Fresche Bio-Sciences in India, Bangladesh, Nepal, and Sri Lanka. The company distributes and markets Si QAC (Silicon Quaternary Ammonium Compound) antimicrobial technology, which is a surface-bonded, non-leaching, non-depleting treatment that functions by mechanically destroying pathogen cell walls through a covalent 'lock and bond' mechanism. The technology avoids chemical biocidal action, eliminating the risk of antimicrobial resistance development and providing durable protection ranging from 24 hours on hands to the service life of treated textiles and surfaces.
The product portfolio includes FRESCHE EF 3851 as the flagship hospital-grade surface disinfectant, BZ1 Binder as a durability-enhancing additive for textile substrates, and the SIQURA line of Hand Protectant and Surface Protectant products. Pricing for consumer-facing SKUs is in the ₹799-₹8,000 range per unit, with treatment services and OEM licensing available for larger commercial deployments. The company sells through a multi-channel model combining direct B2B sales, a PAN India dealership and distributor network, OEM technology licensing with co-branding, antimicrobial services contracts, and a direct e-commerce storefront.
Customers served span healthcare providers (KG Hospital, KMCH Hospital, MEDICA Superspecialty Hospital — validated for surface and linen treatment), hospitality chains, textile manufacturers, footwear producers, food and beverage processors, institutional facilities, and government/public sector buyers. The technology is differentiated by major regulatory approvals (US EPA, EU BPR, OEKO-TEX) and is positioned for the high hospital-acquired infection burden in India (10-30% of inpatients vs. ~5% in Western markets). Parent entity Fresche Bioscience, headquartered in Melbourne, retains R&D responsibility and operates its own sales offices in Australia, New Zealand, and China.
Guardian Health Management - Fresche Bioscience firmographics
Firmographics- Name
- Guardian Health Management - Fresche Bioscience
- Legal name
- Guardian Health Management Pvt Ltd
- Website
- https://ghmindia.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Guardian Health Management is the India-headquartered exclusive regional distributor for Australia-based Fresche Bio-Sciences' Si QAC surface-bonded antimicrobial technology, serving healthcare, hospitality, textile, and institutional customers across South Asia with hospital-grade disinfectants, treatment services, and OEM licensing.
- Ownership category
- akta.pro rank
Guardian Health Management - Fresche Bioscience industry classification
Industry- Product category
- Antimicrobial coatings and hygiene products
- NAICS
- Soap and Cleaning Compound Manufacturing (32561)
- SIC
- Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts) (AFAJAFAF)
Keywords
Where Guardian Health Management - Fresche Bioscience is headquartered
LocationHeadquarters
- HQ city
- Bengaluru (Bangalore)
- HQ country
- India
- HQ region
- Asia
Offices6 records
Markets served
Guardian Health Management - Fresche Bioscience business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel
Revenue model
- Antimicrobial Product Sales: Direct sales of Fresche antimicrobial products including EF 3851 hospital-grade disinfectant, BZ1 Binder for durability enhancement, Fresche Mini Kit for small-scale application, SIQURA Hand Protectant and SIQURA Surface Protectant. Products sold through direct channel and dealer network.
- Technology Licensing and OEM: Licensing technology to manufacturing partners for development of antimicrobial-protected products with co-branding arrangements. Partners span diverse industries including textiles, footwear, sanitary products, and industrial materials.
- Antimicrobial Services Contracts: Service business offering antimicrobial treatment application services to end customers including healthcare facilities, commercial establishments, and institutional clients.
- Distribution and Dealership: Revenue through PAN India distributorship and dealership network, where partners purchase products for resale to end users.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Combo Pack - Fresche EF 3851 (1L) + BZ1 Binder (1.5L) |
| Unit Pricing | Pay-as-you-go | SIQURA Hand Protectant 475ml |
| Unit Pricing | Pay-as-you-go | SIQURA Hand Protectant 5L |
| Unit Pricing | Pay-as-you-go | Fresche Mini Kit |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels3 records
Guardian Health Management - Fresche Bioscience product offering
Product offeringCore offering
Guardian Health Management, the Indian arm of Australia's Fresche Bioscience (part of the Guardian Group), manufactures and distributes Si QAC-based antimicrobial products including surface and hand protectants under the SIQURA brand, textile treatment chemicals (FRESCHE EF 3851, BZ1 Binder), and consumer kits. The company also provides antimicrobial treatment services for textiles supplied to footwear, automotive, healthcare, and hospitality sectors.
Product overview
Fresche Bioscience is a surface-bonded antimicrobial technology platform marketed in India by Guardian Health Management. The portfolio centers on Si QAC (Silicon Quaternary Ammonium Compound) antimicrobial technology that provides durable, non-leaching, non-depleting microbial protection through a mechanical mode of action. The core products include FRESCHE EF 3851 as the primary surface disinfection treatment, supported by BZ1 Binder as an additive to enhance durability on synthetic and cellulosic substrates. SIQURA product line extends the technology to consumer-facing applications with Hand Protectant (24-hour protection) and Surface Protectant (24 hours to 30 days protection depending on surface type). Products are available in various sizes from mini kits for trial use to commercial volumes, and are applicable across healthcare, hospitality, textiles, food processing, footwear, and institutional settings.
Differentiator
Problem solved
Functional benefit
Brands
- FRESCHE EF 3851: High performance hospital-grade surface disinfection treatment delivering long-term bacterial, fungal, mould and odour control.
- BZ1 Binder
- SIQURA
Products and services
- SIQURA Hand Protectant A long-lasting antimicrobial hand protectant based on Si QAC technology, designed for individual consumers, hospitals, and institutions seeking durable hand hygiene protection.
- SIQURA Surface Protectant A Si QAC-based antimicrobial spray for surfaces, designed for households, healthcare facilities, and hospitality venues requiring long-lasting surface hygiene.
- FRESCHE EF 3851 An industrial Si QAC antimicrobial formulation used to treat textiles and other substrates, providing long-lasting antimicrobial protection for downstream manufactured goods.
- BZ1 Binder A binder formulation used alongside Fresche Si QAC antimicrobial treatments to ensure durable bonding of antimicrobial actives to textile substrates.
- Fresche Mini Kit A consumer kit bundling Fresche antimicrobial products for personal and household use, designed as an entry-level offering for individual buyers.
- SIQURA Combo Pack A combined retail pack bundling SIQURA Hand Protectant and SIQURA Surface Protectant for consumers seeking full hand and surface antimicrobial coverage.
- Antimicrobial Textile Treatment Service A B2B service providing antimicrobial treatment of textiles using Si QAC and Lock and Bond technology for OEM manufacturers in footwear, automotive, healthcare, and apparel sectors.
Quantifiable outcome
- 99.9% terminal bacterial knock-down on treated surfaces
- +5 more outcomes
Companies that use Guardian Health Management - Fresche Bioscience
Customer profileNamed customers3 records
Segments8 records
Ideal customer profiles2 records
Guardian Health Management - Fresche Bioscience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Guardian Health Management - Fresche Bioscience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fresche Bio-SciencescoreGuardian Health Management is the exclusive representative for Fresche Bio-Sciences products in India, Bangladesh, Nepal and Sri Lanka. Fresche Bio-Sciences is an Australian multinational specializing in research, development and distribution of next-generation molecular compounds for microbial control and surface protection.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Guardian Health Management - Fresche Bioscience competitors and assessment
Company assessmentDirect peers
- Microban International: US-headquartered global leader in built-in antimicrobial technologies for textiles, polymers, and coatings. Direct comparable as both firms license antimicrobial additive technology to OEMs across consumer and industrial product categories.
- SANITIZED AG: Swiss specialist in antimicrobial hygiene functions for textiles and polymers, with deep textile-mill partnerships. Direct peer given overlapping product positioning on durable antimicrobial textile finishes and surface protection additives.
- BioCote: UK-based antimicrobial technology company providing silver-ion and other additive solutions to manufacturers of plastics, textiles, and consumer products. Directly comparable as an OEM-licensing antimicrobial technology platform targeting similar end-markets.
- Sciessent (Agion): US-based provider of antimicrobial and odor-control solutions for healthcare, textile, and industrial applications. Comparable in its licensing model and broad vertical reach into healthcare, apparel, and building products.
Broad incumbents
- Reckitt Benckiser (Dettol/Lysol): Global FMCG major with dominant disinfectant brands (Dettol, Lysol) in India. Broad incumbent in the surface disinfection and hand hygiene categories that overlap with SIQURA product positioning.
- Ecolab: Global leader in water, hygiene, and infection prevention solutions serving healthcare, hospitality, and food service in India. Broad incumbent with deep institutional sales coverage that overlaps with FRESCHE/SIQURA service and product offerings.
- 3M (Health Care/Infection Prevention): Global diversified manufacturer with significant infection prevention, surface disinfection, and healthcare hygiene product lines in India. Broad incumbent that competes for hospital and institutional buyers' antimicrobial budgets.
Emerging players
- Cupron: US-based antimicrobial copper technology firm licensing copper-based antimicrobial additives for textiles, medical devices, and industrial applications. Comparable niche peer in the specialty antimicrobial technology licensing space.
- PurThread Technologies: US-based antimicrobial textile technology firm embedding active agents into fibers for healthcare and consumer apparel. Comparable as a technology-licensing player focused specifically on healthcare textile infection prevention.
Regional players
- Eureka Forbes: Indian market leader in consumer water purification and home hygiene, with growing commercial disinfection and hospital hygiene offerings. Regional incumbent in India with strong brand and direct sales force.
Market position
Strengths4 records
Weaknesses2 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Guardian Health Management - Fresche Bioscience social profiles
Digital presenceGuardian Health Management - Fresche Bioscience compliance and trust
Trust signalCompliance3 records
Guardian Health Management - Fresche Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Guardian Health Management - Fresche Bioscience leadership team
Management profileNumber of profiles
Guardian Health Management - Fresche Bioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Guardian Health Management - Fresche Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Guardian Health Management - Fresche Bioscience
What does Guardian Health Management - Fresche Bioscience do?
Guardian Health Management, the Indian arm of Australia's Fresche Bioscience (part of the Guardian Group), manufactures and distributes Si QAC-based antimicrobial products including surface and hand protectants under the SIQURA brand, textile treatment chemicals (FRESCHE EF 3851, BZ1 Binder), and consumer kits. The company also provides antimicrobial treatment services for textiles supplied to footwear, automotive, healthcare, and hospitality sectors.
Is Guardian Health Management - Fresche Bioscience a public or private company?
Guardian Health Management - Fresche Bioscience is a private company. It is classified as corporate owned and is currently operating.
When was Guardian Health Management - Fresche Bioscience founded?
Guardian Health Management - Fresche Bioscience was founded in -1. It employs 1 to 10 people.
Where is Guardian Health Management - Fresche Bioscience based?
Guardian Health Management - Fresche Bioscience is headquartered in Bengaluru (Bangalore), India, in the Asia region.
How does Guardian Health Management - Fresche Bioscience make money?
Four revenue lines are on record. Antimicrobial Product Sales are the primary driver. The others are technology Licensing and OEM, antimicrobial Services Contracts and distribution and Dealership.
Who are Guardian Health Management - Fresche Bioscience's main competitors?
Direct peers on record are Microban International, SANITIZED AG, BioCote and Sciessent (Agion). Broad incumbents are Reckitt Benckiser (Dettol/Lysol), Ecolab and 3M (Health Care/Infection Prevention). Emerging players are Cupron and PurThread Technologies. Eureka Forbes is listed as a regional player.
Does Guardian Health Management - Fresche Bioscience have an API?
No public API is recorded for Guardian Health Management - Fresche Bioscience.
What industry is Guardian Health Management - Fresche Bioscience in?
Guardian Health Management - Fresche Bioscience's product category is Antimicrobial coatings and hygiene products. Its primary akta.pro industry code is AFAJAFAF, Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts). Its NAICS code is 32561 and its SIC code is 2890.